Detalles de la búsqueda
1.
Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus.
Int J Mol Sci
; 25(5)2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38474267
2.
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis.
Ann Rheum Dis
; 78(3)2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30552173
3.
Serum Advanced Glycation End Products and Their Soluble Receptor as New Biomarkers in Systemic Lupus Erythematosus.
Biomedicines
; 12(3)2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38540223
4.
Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period.
RMD Open
; 10(2)2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38631846
5.
Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes.
Genome Biol
; 25(1): 68, 2024 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38468286
6.
Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register.
Semin Arthritis Rheum
; 64: 152341, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38128174
7.
Corrigendum: Impact of Non-Persistence on Healthcare Resource Utilization Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study.
Front Pharmacol
; 13: 867017, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35341215
8.
Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study.
Front Med (Lausanne)
; 9: 888377, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35783644
9.
The synovial and blood monocyte DNA methylomes mirror prognosis, evolution, and treatment in early arthritis.
JCI Insight
; 7(9)2022 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35324478
10.
Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry.
Rheumatol Ther
; 9(4): 1031-1047, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35467242
11.
Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis.
EBioMedicine
; 80: 104053, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35576644
12.
Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study.
Front Pharmacol
; 13: 980832, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263118
13.
Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study.
Front Pharmacol
; 12: 752879, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34912219
14.
Non-invasive vagus nerve stimulation for rheumatoid arthritis: a proof-of-concept study.
Lancet Rheumatol
; 3(4): e262-e269, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38279410
15.
Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project.
J Clin Med
; 10(3)2021 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33498379
16.
Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register.
Arthritis Res Ther
; 22(1): 143, 2020 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539800
17.
Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab: ACT-AXIS study.
Medicine (Baltimore)
; 98(26): e15947, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31261500
18.
Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry.
Rheumatol Ther
; 9(5): 1475-1476, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36063343
19.
Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT study. / Retraso diagnóstico y terapéutico de la artritis reumatoide y su relación con dispositivos asistenciales en Catalunya. Estudio AUDIT.
Reumatol Clin
; 12(3): 146-50, 2016.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-26362843
20.
Tocilizumab may induce secondary hypogammaglobulinaemia. A retrospective case series of 42 patients.
Joint Bone Spine
; 87(5): 503-505, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360832